文献速递肝病消化道肿瘤与早癌

通过新抗原驱动的T细胞受体分离解锁肝细胞癌新型T细胞免疫治疗

Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.
PubMed 文献 · Gut · 2025-06-06

本研究分析晚期肝细胞癌患者的肿瘤、肝脏灌洗液和肝引流淋巴结中的T细胞对新抗原的反应性,从7例患者中预测出542个候选新抗原,经体外刺激确认14个靶点有反应性,反应性T细胞多来自肝脏灌洗液和淋巴结,提示这些来源的T细胞及TCR或可用于肝细胞癌免疫治疗。

要点

  • 从7例晚期肝细胞癌患者预测出542个候选新抗原,选出78个新抗原及11个驱动癌基因热点靶点进行体外T细胞刺激。
  • 共培养实验确认14个靶点有反应性,多数反应性T细胞来自肝脏灌洗液和引流淋巴结。
  • 肝脏灌洗液来源T细胞呈中枢记忆和效应记忆CD4+伴细胞毒性效应表型,引流淋巴结以组织驻留记忆CD4+和CD8+耗竭表型为主。

核心结论

  • 研究揭示了肝细胞癌微环境内外新抗原反应性T细胞的功能特征,肝脏灌洗液和肿瘤引流淋巴结分离的T细胞及TCR或可作为肝细胞癌免疫治疗的来源。

研究设计与样本

  • 研究分析晚期肝细胞癌患者的肿瘤、肝脏灌洗液和肝引流淋巴结样本,测试分离T细胞对预测新抗原的反应性。
  • 采用单细胞RNA测序评估抗原经验T细胞的转录组和蛋白质组谱,并分离表达4-1BB的新抗原反应性T细胞进行T细胞受体测序。

主要发现

  • 生物信息学分析从7例患者中鉴定出542个候选新抗原,其中78个新抗原和11个肝细胞癌驱动癌基因热点靶点被选用于体外T细胞刺激。
  • 共培养实验确认14个靶点有反应性,多数反应性T细胞来自肝脏灌洗液和淋巴结。
  • 肝脏灌洗液来源T细胞表现为中枢记忆和效应记忆CD4+伴细胞毒性效应谱,而组织驻留记忆CD4+和CD8+耗竭谱T细胞主要在引流淋巴结中鉴定。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumour-infiltrating T cells can mediate both antitumour immunity and promote tumour progression by creating an immunosuppressive environment. This dual role is especially relevant in hepatocellular carcinoma (HCC), characterised by a unique microenvironment and limited success with current immunotherapy. OBJECTIVE: We evaluated T cell responses in patients with advanced HCC by analysing tumours, liver flushes and liver-draining lymph nodes, to understand whether reactive T cell populations could be identified despite the immunosuppressive environment. DESIGN: T cells isolated from clinical samples were tested for reactivity against predicted neoantigens. Single-cell RNA sequencing was employed to evaluate the transcriptomic and proteomic profiles of antigen-experienced T cells. Neoantigen-reactive T cells expressing 4-1BB were isolated and characterised through T-cell receptor (TCR)-sequencing. RESULTS: Bioinformatic analysis identified 542 candidate neoantigens from seven patients. Of these, 78 neoantigens, along with 11 hotspot targets from HCC driver oncogenes, were selected for ex vivo T cell stimulation. Reactivity was confirmed in co-culture assays for 14 targets, with most reactive T cells derived from liver flushes and lymph nodes. Liver flush-derived T cells exhibited central memory and effector memory CD4+ with cytotoxic effector profiles. In contrast, tissue-resident memory CD4+ and CD8+ T cells with an exhausted profile were primarily identified in the draining lymph nodes. CONCLUSION: These findings offer valuable insights into the functional profiles of neoantigen-reactive T cells within and surrounding the HCC microenvironment. T cells isolated from liver flushes and tumour-draining lymph nodes may serve as a promising source of reactive T cells and TCRs for further use in immunotherapy for HCC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Maravelia P, Yao H, Cai C, et al. Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut. 2025. PMID: 39832892. doi:10.1136/gutjnl-2024-334148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。